Global Oncology Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Oncology Market was valued at $285 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.2% CAGR, to an estimated market size of $485 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global oncology market encompasses the comprehensive ecosystem for the diagnosis, treatment, and management of cancer. This includes pharmaceutical interventions such as chemotherapy, immunotherapy, targeted therapy, and hormonal therapy, as well as diagnostic technologies including imaging, biomarker testing, and liquid biopsies. The scope excludes general hospital infrastructure not specifically dedicated to oncology care.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Oncology Market in the period 2025-30:
- The rising global cancer burden is driven by aging populations and lifestyle factors, with new cases projected to increase significantly by 2040.
- A major shift toward precision medicine is occurring, where treatments are tailored to individual genetic profiles to improve efficacy and reduce toxicity.
- The rapid adoption of immunotherapy and antibody-drug conjugates (ADCs) is transforming the standard of care across multiple tumor types.
- Integration of artificial intelligence is enhancing diagnostic accuracy in medical imaging and accelerating the drug discovery process.
- Advancements in early detection technologies, such as liquid biopsies and next-generation sequencing, are improving patient survival rates through earlier intervention.
- The market is seeing increased biosimilar competition, which is expected to provide budget relief for healthcare systems as major oncology patents expire.
- Expansion of CAR-T cell therapy from hematological malignancies to solid tumors represents a significant frontier for clinical development.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia Pacific
- Rest of World
Segments
- Cancer Treatment
- Cancer Diagnostics & Screening